Table 2. The relationship between miR-199b expression and clinicopathologic characteristics in CRC patients.
Parameters | miR-199b expression | Chi-square value | P value | ||
---|---|---|---|---|---|
High (n=32) | Low (n=28) | Total (n=60) | |||
Age(y) | |||||
≤60 | 13 | 12 | 25 | 0.031 | 0.861 |
> 60 | 19 | 16 | 35 | ||
Gender | |||||
Female | 16 | 17 | 33 | 0.693 | 0.405 |
Male | 16 | 11 | 27 | ||
Tumor size(cm) | |||||
≤2 | 10 | 14 | 24 | 2.188 | 0.139 |
>2 | 22 | 14 | 36 | ||
Tumor differentiation | |||||
Well/moderate | 17 | 20 | 37 | 2.116 | 0.146 |
Poor | 15 | 8 | 23 | ||
TNM stage | |||||
I+II | 20 | 10 | 30 | 4.286 | 0.038* |
III+IV | 12 | 18 | 30 | ||
Lymph node metastasis | |||||
Positive | 13 | 13 | 26 | 0.205 | 0.651 |
Negative | 19 | 15 | 34 | ||
Distant metastasis | |||||
Positive | 10 | 16 | 26 | 4.077 | 0.044* |
Negative | 22 | 12 | 34 |
Statistically significant (P<0.05)